VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,209 | +55.3% | 41,672 | +140.3% | 0.00% | +50.0% |
Q1 2024 | $1,422 | -96.9% | 17,340 | +73.4% | 0.00% | – |
Q1 2020 | $46,000 | -66.2% | 10,001 | -39.4% | 0.00% | -100.0% |
Q2 2019 | $136,000 | -17.1% | 16,500 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $164,000 | +30.2% | 16,500 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $126,000 | -59.7% | 16,500 | -8.3% | 0.00% | 0.0% |
Q3 2018 | $313,000 | – | 18,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |